Submit your Baycol claim details for a free, no obligation case review
Get Started:
In August 2001, the anti-cholesterol drug Baycol was recalled. Part of the class of drugs called statins all statins have been associated to the rare and deadly condition involving muscle complication called rhabdomyolysis. Statins were considered a revolutionary treatment to lower cholesterol, but Baycol was found to have an increased likelihood of causing rhabdomyolysis than other statin drugs, resulting in around 100 Baycol patient deaths worldwide. At the time of the Baycol recall, 8 million Americans were taking statins.
Expected to hit the $875 million mark in 2001, the Baycol recall caused many cholesterol-lowering patients to discontinue the use of other statin drugs as well. Statins are the most widely prescribed class of cholesterol-lowering drugs, and was one of the fastest growing segments of the drug industry. Following the Baycol recall, Public Citizen consumer advocacy group petitioned the FDA to add a black box warning to the remaining five statins available on the market, warning patients of the serious and deadly risks found to occur with the drug class. The petition noted there had been an additional 50 deaths as the result of other statin drugs than Baycol.
Rhabdomyolysis, a rare side effect of prescription drugs that causes muscle cells to break down and allows cell contents to enter the bloodstream, was found linked to Baycol. After the Baycol recall was announced, the health minister of Germany attacked the Leverkusen based manufacturer of Baycol saying the company left doctors and patients in the dark about Baycol and should have acted sooner to release the information. The highest risk patients for Baycol side effects were elderly patients and those combining Baycol with gemfibrozil.
An editorial in the Journal of the American Medical Association is one of just several articles to appear in next week’s edition that focuses on the FDA’s ability to effectively monitor drug safety. Following the September Vioxx recall, more critics h...
Bayer''s Baycol cholesterol drug was recalled in August 2001 and is now linked to over 100 deaths. The company has so far paid $842 million to settle 2,224 cases but still faces 9,948 more Baycol cases. Now the company is facing a class action in Penns...
1 Stop Baycol Lawyer - Baycol has been withdrawn for serious side effects
FDA - Baycol - Read about Bayer Pharmaceutical Division''s recall of this cholesterol-lowering drug. Includes an FDA talk paper.
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice